Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.
Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedLocations section now lists Texas (Houston, MD Anderson Cancer Center). Page revision updated to v3.3.3.SummaryDifference0.2%
- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check40 days agoChange DetectedRemoved the government funding lapse notice regarding NIH operations; the study details page now presents the trial information without that notice.SummaryDifference0.3%
- Check54 days agoChange DetectedCore study details such as title, conditions, locations, eligibility criteria, and primary outcomes remain unchanged, while minor formatting/layout tweaks and the addition of a results section were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check83 days agoChange DetectedMajor change: page now advertises a government operating-status notice and updates the release version to v3.2.0; the previous v3.1.0 version tag was removed.SummaryDifference2%
- Check90 days agoChange DetectedMajor update: expanded immune biology terminology and a version upgrade to v3.1.0, replacing v3.0.2.SummaryDifference0.7%
Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.